Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

Half of all patients with multiple sclerosis (MS) experience cognitive impairment, for which there is no pharmacological treatment. Using magnetic resonance spectroscopy (MRS), we examined metabolic changes in the hippocampi of MS patients, compared the findings to performance on a neurocognitive te...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rahn, Kristen A., Watkins, Crystal C., Alt, Jesse, Rais, Rana, Stathis, Marigo, Grishkan, Inna, Crainiceau, Ciprian M., Pomper, Martin G., Rojas, Camilo, Pletnikov, Mikhail V., Calabresi, Peter A., Brandt, Jason, Barker, Peter B., Slusher, Barbara S., Kaplin, Adam I.
Natura: Artigo
Lingua:Inglês
Pubblicazione: National Academy of Sciences 2012
Soggetti:
Biological Sciences
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523869/
https://ncbi.nlm.nih.gov/pubmed/23169655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1209934109
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi